Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control
11.Safety on the off-label use of glutathione solution for injection (IV)
Abbreviations CKD: Chronic kidney disease DKA: Diabetic ketoacidosis FDA: US Food and Drug Administration GLP-1 RA: Glucagon-like peptide-1 receptor agonist HCO: Healthcare organisation IHD: Ischaemic heart disease PSM: Propensity score matching SGLT2i: Sodium-glucose cotransporter 2 inhibitor SSMD: Strictly standardised mean difference UTI: Urinary tract infection References Gregory GA, Robinson TIG, Linklater SE et al (2022) Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study
When you get into very large patient populations and have millions of patients using your medicine, you have different types of medical conditions among those patients, Jorgensen said
Among molecules that are controlled by GCs and may be involved in the control of insulin signaling, myostatin has drawn a particular interest
If Rybelsus was prescribed for type 2 diabetes management and you want to move to an injectable option, your healthcare provider may consider Ozempic instead, as it is also approved for type 2 diabetes
